Want to join the conversation?
$ICPT 2Q15 Call: We’ll target enrollment of 1400 NASH patients with stage II/III fibrosis. After 72 weeks of treatment these patients will undergo liver biopsy & interim analysis will be performed. Histology data collected in these patients will form basis for anticipated accelerated approval filing to market OCA for treatment of NASH with fibrosis
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?